-
News | 2017.09.26
Report on the 49th Institut Pasteur International Network Directors' Council in Abidjan
The annual Institut Pasteur International Network Directors’s Council closed on Friday 22nd September in Abidjan in the presence of Christian Vigouroux, Chairman of the Institut Pasteur’s Board of Directors. During the 3 days of the meeting, representatives of the 33 member institutes were able to take stock of the main axes of development such as the scientific strategy of the network,...
-
News | 2017.09.01
The FioCruz-Pasteur-USP tripartite agreement is bearing fruits
Under the terms of the Tripartite Agreement between the Oswaldo Cruz Foundation, the University of Sao Paulo and the Institut Pasteur, the newly created Pasteur / USP Scientific Platform will be launched by the end of 2017. This partnership offers the possibility to develop integrated actions in research, technology and innovation around a scientific strategy that has been defined by the partners...
-
News | 2017.09.29
Three projects from the Institut Pasteur in Dakar and Madagascar selected for funding by AESA’s Grand Challenge Africa
The African Academy of Sciences and the NEPAD Agency’s Alliance for Accelerating Excellence in Science in Africa (AESA) announced funding for eight African innovators to tackle maternal, neonatal and child health on the Continent. Among them 2 teams from the Institut Pasteur in Dakar and one from the Institut Pasteur in Madagascar were selected from among about 400 applicants from 20 African...
-
News | 2017.09.29
Institut Pasteur and Hamad Bin Khalifa University will collaborate on training in the areas of genome research , precision medicine and disease prevention
Today, Pr Christian Bréchot welcomed on the Institut Pasteur’s campus in Paris, Her Excellency Sheikha Hind bint Hamad Al Thani, Chairperson of Hamad Bin Khalifa University, Vice-Chairperson and CEO of Qatar Foundation to sign a Memorandum of Understanding. This agreement will allow the two institutions to cooperate in the fields of academics, research, teaching and knowledge sharing...
-
Article | 2017.10.03
Affiliation to Doctoral Schools
The research units and laboratories of Institut Pasteur are affiliated to different Parisian doctoral schoolsDownload the table of affiliationBioSPCBio Sorbonne Paris CitéBoard member of the doctoral school representing the Institut Pasteur: M. SalaUseful documents:Presentation (only available in French)Rules of Procedures (only available in French)Scientific publications signature...
-
Document de presse | 2017.10.06
Colon cancer: APC protein affects immunity by preventing pre-cancerous inflammation
Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis. Research led by scientists at the Institut Pasteur, CNRS and Inserm have recently demonstrated that mutations to this gene do not only lead to the emergence of colon polyps; they also harm the immune system, leaving it unable to...
-
News | 2017.10.06
Support for government policy for the prevention of infectious diseases
Scientific, medical, paramedical societies, medical unions and the Institut Pasteur, all signatories below, support the policy for the prevention of infectious diseases implemented by the French Government and the Minister of Health.Vaccines are one of the major achievements of medicine, this is why the companies which sign this text, including the Institut Pasteur, support the French Government'...
-
News | 2017.10.09
A new survival mechanism of the tubercle bacillus unveiled
The fight against infectious bacteria requires the understanding at the molecular level of the defense strategies, often very elaborate, that they deploy to counteract and defuse the host's defenses. Since Metchnikoff's precursor work, special attention has been paid to the specific mechanisms by which bacteria can combat the acidity of phagosomes; vesicles inside which they are enclosed to...
-
Fiche maladie | 2017.10.11
Plague
Plague is still rife in Africa, Asia and America. It is considered as one of the world's re-emerging diseases and is subject to international regulations. WHO is reporting an increasing number of cases in some regions. During the 20th century, the use of antibiotic treatments and strengthening of public health measures significantly reduced morbidity and mortality from plague but were not able to...
-
News | 2017.10.11
Destroying Helicobacter pylori by disrupting synthesis of its cell wall!
Researchers from the Institut Pasteur and the CNRS have recently demonstrated that it is possible to destroy the cell wall of a bacterium by simply disrupting the assembly of two proteins. They focused on Helicobacter pylori, a model bacterium for this type of study. Their research has revealed the structure of a protein complex, which is vital for cell wall synthesis. And they have proved that,...
